Literature DB >> 9316478

Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity.

M K Eskandari1, J C Kalff, T R Billiar, K K Lee, A J Bauer.   

Abstract

Bacterial lipopolysaccharide (LPS) is a causative agent of sepsis-induced ileus. Although it is known that LPS activates macrophages and initiates inflammation, the consequences of LPS on the macrophage network and a potential inflammatory response within the intestinal muscularis have not been investigated. This study was designed to identify cellular and functional changes in rat intestinal muscularis after intraperitoneal LPS. Histo- and immunohistochemistry were used to phenotype leukocytes. Functional alterations were determined using an organ bath. Compared with controls, LPS caused a 21-fold increase in staining for the lymphocyte activation marker-1 (LFA-1) localized to the ED2+ macrophage network 1 h after injection. This was followed by a significant infiltration of neutrophils, mast cells, and monocytes into the muscularis. LPS also caused a 62% reduction in spontaneous circular muscle activity and a 91% suppression of bethanechol-stimulated contractions 12 h after injection. These results demonstrate that endotoxemia 1) acutely activates the muscularis macrophage network, 2) causes the extravasation of leukocytes, and 3) results in circular muscle impairment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316478     DOI: 10.1152/ajpgi.1997.273.3.G727

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  43 in total

1.  Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis.

Authors:  Nicolas T Schwarz; Donna Beer-Stolz; Richard L Simmons; Anthony J Bauer
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

2.  Effect of lipopolysaccharide on small intestinal L-leucine transport in rabbit.

Authors:  B Abad; J E Mesonero; M T Salvador; J Garcia-Herrera; M J Rodriguez-Yoldi
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

Review 3.  Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis.

Authors:  B M Buchholz; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-03       Impact factor: 3.598

Review 4.  Interstitial cells of Cajal at the clinical and scientific interface.

Authors:  Kenton M Sanders
Journal:  J Physiol       Date:  2006-08-31       Impact factor: 5.182

5.  Macrophages in the small intestinal muscularis externa of embryos, newborn and adult germ-free mice.

Authors:  Hanne B Mikkelsen; Charly Garbarsch; Jørgen Tranum-Jensen; Lars Thuneberg
Journal:  J Mol Histol       Date:  2004-05       Impact factor: 2.611

6.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  The macrophage system in the intestinal muscularis externa during inflammation: an immunohistochemical and quantitative study of osteopetrotic mice.

Authors:  H B Mikkelsen; J O Larsen; H Hadberg
Journal:  Histochem Cell Biol       Date:  2008-04-08       Impact factor: 4.304

8.  Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus.

Authors:  J C Kalff; W H Schraut; R L Simmons; A J Bauer
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

Review 9.  Resident macrophages in the healthy and inflamed intestinal muscularis externa.

Authors:  Sven Wehner; Daniel Robert Engel
Journal:  Pflugers Arch       Date:  2017-02-24       Impact factor: 3.657

10.  Prevention of lipopolysaccharide-induced intussusception in mice by the COX2 inhibitor rofecoxib.

Authors:  Mahmoud Badriyyah; Haggi Mazeh; Stefan Brocke; Venera Osmanova; Herbert R Freund; Menachem Hanani
Journal:  Pediatr Surg Int       Date:  2007-11-06       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.